| Active Not Recruiting | A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P52 in Healthy Male Subjects NCT07367958 | Celltrion | Phase 1 |
| Active Not Recruiting | A Study to Evaluate the PK Similarity of AK112 in Healthy Chinese Male Subjects NCT07340476 | Akeso | Phase 1 |
| Completed | A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P43 in Healthy Male Subjects NCT06951828 | Celltrion | Phase 1 |
| Completed | A Drug-drug Interaction Study With TS-172 in Healthy Adult Male Subjects NCT06837142 | Taisho Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | A Mass Balance Study of TS-172 in Healthy Adult Subjects NCT06596356 | Taisho Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | A Study of PET/CT Imaging Using INR101 Injection in Healthy Male Subjects and Patients With Suspected Prostate NCT06472531 | Yunhe Pharmaceutical (Tianjin) Co., Ltd | Phase 1 / Phase 2 |
| Completed | To Compare the Pharmacokinetics, Safety and Immunogenicity of CT-P55 and Cosentyx in Healthy Subjects NCT07054970 | Celltrion | Phase 1 |
| Completed | Compare the Pharmacokinetics and Safety of BAT3306 Injection Versus KEYTRUDA® Administered in Healthy Male Sub NCT06111196 | Bio-Thera Solutions | Phase 1 |
| Completed | ADME Study of [14C] Yiqibuvir in Healthy Male Subjects NCT05998304 | Sunshine Lake Pharma Co., Ltd. | Phase 1 |
| Completed | Study of RPT193 in Healthy Adult Male Subjects NCT06087978 | RAPT Therapeutics, Inc. | Phase 1 |
| Completed | A Study to Assess the Effects of Fluvoxamine on Savolitinib Exposure in Healthy Male Subjects NCT05888207 | AstraZeneca | Phase 1 |
| Completed | A Study to Assess the Effects of Savolitinib on the Pharmacokinetics of Digoxin, Rosuvastatin, Metformin, and NCT05768360 | AstraZeneca | Phase 1 |
| Completed | Bioequivalence Study of Tafolecimab Injections in Chinese Healthy Male Volunteers NCT05792917 | Innovent Biologics (Suzhou) Co. Ltd. | Phase 1 |
| Completed | ADME Study of [14C] Antaitavir Hasophate in Healthy Male Subjects NCT05446233 | Sunshine Lake Pharma Co., Ltd. | Phase 1 |
| Completed | A Study to Evaluate the PK Similarity of AK104 in Healthy Chinese Male Subjects NCT05559554 | Akeso | Phase 1 |
| Completed | A Mass Balance Study of [14C] TAS-303 in Healthy Adult Male Subjects NCT05621447 | Taiho Pharmaceutical Co., Ltd. | Phase 1 |
| Unknown | A Clinical Trial of XZP-3287 for Material Balance NCT05478109 | Xuanzhu Biopharmaceutical Co., Ltd. | Phase 1 |
| Completed | AVT03 With Prolia in Healthy Male Subjects NCT05126784 | Alvotech Swiss AG | Phase 1 |
| Completed | A Study in Healthy Male Subjects to Investigate the Comparability of Pharmacokinetics of the Fixed-Dose Combin NCT05275010 | Hoffmann-La Roche | Phase 1 |
| Completed | Phase I Study of Sintilimab in Healthy Chinese Male Subjects NCT05337267 | Innovent Biologics (Suzhou) Co. Ltd. | Phase 1 |
| Completed | Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimila NCT05245669 | Enzene Biosciences Ltd. | Phase 1 |
| Completed | Mass Balance and Biotransformation Study of [14C]DBPR108 in Human NCT05072028 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Phase 1 |
| Completed | A Mass Balance and Biotransformation Study of [14C]SKLB1028 in Chinese Healthy Male Subjects NCT05369858 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Phase 1 |
| Completed | Study of Bevacizumab With Different Manufacturing Process in Healthy Male Subjects NCT05005455 | Innovent Biologics (Suzhou) Co. Ltd. | Phase 1 |
| Completed | Drug Interaction Between SHR4640 Tablets and Furosemide Tablets in Healthy Volunteers (Single Center, Single A NCT04850638 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Completed | A Comparative Study of TG103 Produced by Two Manufacturing Processes in Chinese Healthy Male Subjects NCT04839744 | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | Phase 1 |
| Completed | Mass Balance Study of TS-142 in Healthy Adult Subjects. NCT04814771 | Taisho Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | Effects of Collagen Peptide Supplementation on Muscle and Tendon Damage and Function NCT05425407 | KU Leuven | N/A |
| Completed | Mass Balance Study of [14C] TAS-205 in Healthy Volunteers NCT04825431 | Taiho Pharmaceutical Co., Ltd. | Phase 1 |
| Unknown | Relative Bioavailability Study of SHR3680 NCT04903158 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Completed | Mass Balance of Oral [14C]TPN171H in Healthy Male Subjects NCT04655872 | Vigonvita Life Sciences | Phase 1 |
| Completed | A Phase I Study to Evaluate the Safety and Pharmacokinetics of CT-P41 and EU-approved Prolia in Healthy Male S NCT04512872 | Celltrion | Phase 1 |
| Completed | Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-KW-6356 NCT04147910 | Kyowa Kirin, Inc. | Phase 1 |
| Completed | A Drug-drug Interaction Trial of Rifampicin Pharmacokinetics Effect on Fluzoparib NCT04011124 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Completed | A Human AME Study for Omaveloxolone NCT03931590 | Biogen | Phase 1 |
| Completed | Comparison of Pulse Wave and Blood Pressure Measurements Before, During and After Ergometry in Healthy Men NCT03790722 | ARCIM Institute Academic Research in Complementary and Integrative Medicine | N/A |
| Completed | Single Dose Study With Unlabeled Dose and 14C-labeled Microdose of PF-06700841 in Healthy Male Subjects NCT03770039 | Pfizer | Phase 1 |
| Completed | Benznidazole Absorption, Metabolism and Excretion Study NCT03739541 | Exeltis France | Phase 1 |
| Completed | Bioequivalence Study of CJ-30060 in Healthy Male Volunteers NCT03639493 | HK inno.N Corporation | Phase 1 |
| Completed | A Study to Compare the Pharmacokinetics of JHL1149 and Bevacizumab (Avastin) in Healthy Male Volunteers NCT03576651 | JHL Biotech, Inc. | Phase 1 |
| Completed | Study to Investigate the Pharmacokinetic Profile NCT03286829 | Saniona | Phase 1 |
| Completed | Effect of Sodium Nitroprusside on Cerebral Blood Flow NCT03317652 | Rigshospitalet, Denmark | N/A |
| Completed | Pharmacokinetic, Safety and Immunogenicity Phase I Study of HLX04 Versus Avastin® in Healthy Male Subjects NCT03483649 | Shanghai Henlius Biotech | Phase 1 |
| Completed | Mass Balance Study of FYU-981 NCT02901366 | Fuji Yakuhin Co., Ltd. | Phase 2 |
| Completed | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and NCT02632526 | AstraZeneca | Phase 1 |
| Completed | Mass Balance and Metabolism Study of 14C-Z-215 NCT02618629 | Zeria Pharmaceutical | Phase 1 |
| Unknown | Investigate a Interaction of Candesartan and Atorvastatin in Healthy Male Sugjects NCT02609711 | Ahn-Gook Pharmaceuticals Co.,Ltd | Phase 1 |
| Withdrawn | A Study to Compare the Pharmacokinetics of Different Formulations of AZD9977 and the Influence of Food in Heal NCT02560363 | AstraZeneca | Phase 1 |
| Completed | Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivikar Tab. 5/40 mg in Healthy Adult Male S NCT02955498 | Hanlim Pharm. Co., Ltd. | Phase 1 |
| Completed | Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects NCT03648333 | Hanlim Pharm. Co., Ltd. | Phase 1 |
| Unknown | Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Dapoxetine NCT01928563 | Dong-A Pharmaceutical Co., Ltd. | Phase 1 |
| Unknown | Investigate a Pharmacokinetics Between S-pantoprazole 20mg and Pantoprazole 40mg in Healthy Male Subjects NCT01821521 | Ahn-Gook Pharmaceuticals Co.,Ltd | Phase 1 |
| Completed | Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects NCT01819779 | Hanlim Pharm. Co., Ltd. | Phase 1 |
| Completed | Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects NCT01652339 | Hanlim Pharm. Co., Ltd. | Phase 1 |
| Completed | Properties of Dietary Fibre and Energy Intake NCT01257295 | Wageningen University | N/A |
| Completed | Evaluation of Dose-response, Pharmacodynamic and Pharmacokinetic Bioequivalence of Filgrastim in Healthy Male NCT01933971 | Bio-ker S.r.l. | Phase 1 |
| Completed | A Study to Find Out How YM150 is Absorbed Into and Eliminated From the Body in Healthy Male Subjects NCT01657981 | Astellas Pharma Europe B.V. | Phase 1 |
| Completed | Effect of Uridine on GABA and High Energy Phosphate Levels in Healthy Volunteers NCT01261260 | Mclean Hospital | Phase 1 |
| Unknown | Investigate a Pharmacodynamics Between S-pantoprazole 10, 20, 40mg and Pantoprazole 20, 40mg in Healthy Male S NCT01882296 | Ahn-Gook Pharmaceuticals Co.,Ltd | Phase 1 |
| Unknown | Investigate a Pharmacokinetic Characteristics and the Safety of AG1502 in Healthy Male Subjects NCT02614352 | Ahn-Gook Pharmaceuticals Co.,Ltd | Phase 1 |